The Q1 22 results remained very healthy More worrying is the downward revision in the group’s outlook, even if it had been somewhat expected The cash generation remained solid. We fear new downward revisions given the still-high level of demand and prices We will adjust our numbers although the valuation is likely to stay broadly unchanged